Evotec Results Presentation Deck
PAGE 1
evotec
Cautionary statement regarding forward-looking statements
Information set forth in this presentation contains forward-looking statements, which involve a number of risks and
uncertainties. All statements other than statements of historical fact are forward-looking statements, which are often
indicated by terms such as "anticipate", "believe", "could", "estimate", "expect", "goal", "intend", "look forward to", "may",
"plan", "potential", "predict", "project", "should", "will", "would" and similar expressions. The forward-looking statements
contained herein represent the judgement of Evotec as of the date of this presentation. Such forward-looking statements
are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our
control, and which could cause actual results to differ materially from those contemplated in these forward-looking
statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such
statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any
such statement is based. Given these risks, uncertainties, and other factors, you should not place undue reliance on these
forward-looking statements.
Note:
The operating business of Evotec GT commenced on 1 April 2020. In addition, the acquisition of the assets (mainly land
and buildings) and the takeover of employees of the Biopark by Sanofi SAS in Toulouse became legally effective on 1 July
2020. The two entities were fully consolidated in the consolidated financial statements from the dates specified above.View entire presentation